The purpose of this study was to characterize the clinical features and com
ponents of 30 patients with isolated cryofibrinogen (CF) versus those of 19
patients with combined CF and cryoglobulins (CG). Secondary forms of cryof
ibrinogenaemia associated with collagen disorders, infectious or malignant
diseases, were significantly more frequent in patients with combined CF and
CG than those with isolated CF (79 versus 47%, P = 0.02). Both groups of C
F patients presented predominantly cutaneous symptoms (77% in isolated CF;
58% in combined CF + CG), and less frequently venous and/or arterial thromb
osis (13% in isolated CF; 3% in combined CF + CG). Patients with idiopathic
forms of CF, and particularly those without CG, suffered essentially from
recurrent painful skin ulcers, mainly triggered by cold exposure. Patients
with isolated CF had higher mean plasma concentrations of CF than those wit
h combined CF + CG (1.61 +/- 1.26 versus 0.82 +/- 1.18 g/l, respectively; P
= 0.004), but there was no correlation between the CF plasma level and eit
her the severity of symptoms or the sensitivity to cold. In patients with i
solated CF, fibronectin was suggested (by precipitation analysis) to be a m
ajor component of the cryoprecipitate, whereas immunoglobulins were rarely
present (in only three out of 30 patients). By contrast, in the majority of
patients (78%) with combined CF and CG, the CF consisted mainly of immunog
lobulins of the same class as those characterizing the associated CG. Analy
sis of the CG precipitate revealed the presence of fibronectin but not fibr
inogen, alpha(1)-antitrypsin and alpha(2)-macroglobulin. In conclusion, iso
lated and combined cryofibrinogenaemia are associated with different clinic
al signs requiring different clinical management, but there is no evidence
as yet for a causal role of the cryoprecipitates in the differences observe
d.